‘The field is at a flash­point’: New Chad Mirkin-found­ed biotech hopes to make more ef­fec­tive can­cer vac­cines

Fol­low­ing the suc­cess of the mR­NA Covid vac­cines, can­cer vac­cines are see­ing re­newed in­ter­est af­ter years of mid­dling re­sults. But a group of re­searchers sug­gests …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER